• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清25-羟维生素D3水平可能与新发帕金森病的嗅觉功能障碍有关。

Serum 25-hydroxyvitamin D3 level may be associated with olfactory dysfunction in de novo Parkinson's disease.

作者信息

Kim Ji Eun, Oh Eungseok, Park Jinse, Youn Jinyoung, Kim Ji Sun, Jang Wooyoung

机构信息

Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.

Department of Neurology, Chungnam National University, College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.

出版信息

J Clin Neurosci. 2018 Nov;57:131-135. doi: 10.1016/j.jocn.2018.08.003. Epub 2018 Aug 19.

DOI:10.1016/j.jocn.2018.08.003
PMID:30135017
Abstract

The purpose of our study was to investigate the association between olfactory function in Parkinson's disease (PD) and serum vitamin D status. Thirty-nine patients with de novo PD were enrolled in this study. Olfactory function was assessed by an odor identification test, as a part of the KVSS (Korean version of sniffin' sticks) II test. All patients were also assessed with the NMSS (Non-Motor Symptoms Scale for PD) to check the subjective change in ability to smell. Vitamin D status was determined by measuring the level of serum 25-hydroxyvitamin D3 (25-OHD3). Multiple linear regression tests and correlation analysis were applied to verify the association between serum 25-OHD3 level and patients' subjective and objective olfactory dysfunction. The serum 25-OHD3 level was independently associated with odor identification score in patients with PD (β = 0.38, p < 0.01). Another statistically significant variable was clinical subtype of PD (Intermediate subtype: β = -0.33, p < 0.05; Akinetic rigid type: β = -0.55, p < 0.01). The serum 25-OHD3 level was also negatively correlated with the score for item number 28 in NMSS (Spearman's rho = -0.32, p < 0.05). Our results showed that vitamin D status might be an independent factor for olfactory dysfunction in PD. Although the underlying mechanism has not been clearly identified, we postulate that vitamin D plays a role in the pathogenesis of olfactory dysfunction in PD. Further investigation to elucidate the precise relationship of vitamin D to PD is essential.

摘要

我们研究的目的是调查帕金森病(PD)患者的嗅觉功能与血清维生素D水平之间的关联。本研究纳入了39例初发PD患者。嗅觉功能通过气味识别测试进行评估,该测试是韩国版嗅觉棒(KVSS)II测试的一部分。所有患者还接受了非运动症状量表(NMSS)评估,以检查嗅觉能力的主观变化。通过测量血清25-羟维生素D3(25-OHD3)水平来确定维生素D状态。应用多元线性回归测试和相关性分析来验证血清25-OHD3水平与患者主观和客观嗅觉功能障碍之间的关联。血清25-OHD3水平与PD患者的气味识别得分独立相关(β = 0.38,p < 0.01)。另一个具有统计学意义的变量是PD的临床亚型(中间亚型:β = -0.33,p < 0.05;运动迟缓僵硬型:β = -0.55,p < 0.01)。血清25-OHD3水平也与NMSS中第28项的得分呈负相关(Spearman等级相关系数ρ = -0.32,p < 0.05)。我们的结果表明,维生素D状态可能是PD患者嗅觉功能障碍的一个独立因素。尽管潜在机制尚未明确,但我们推测维生素D在PD嗅觉功能障碍的发病机制中起作用。进一步研究以阐明维生素D与PD的确切关系至关重要。

相似文献

1
Serum 25-hydroxyvitamin D3 level may be associated with olfactory dysfunction in de novo Parkinson's disease.血清25-羟维生素D3水平可能与新发帕金森病的嗅觉功能障碍有关。
J Clin Neurosci. 2018 Nov;57:131-135. doi: 10.1016/j.jocn.2018.08.003. Epub 2018 Aug 19.
2
Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function.根据嗅觉功能对无多巴胺缺乏证据扫描(SWEDD)的分类
J Parkinsons Dis. 2016 Oct 19;6(4):771-778. doi: 10.3233/JPD-160874.
3
Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.药物未治疗的帕金森病伴轻度认知障碍患者的嗅觉功能障碍。
Parkinsonism Relat Disord. 2018 Jan;46:69-73. doi: 10.1016/j.parkreldis.2017.11.334. Epub 2017 Nov 14.
4
Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.帕金森病患者嗅觉功能、运动症状、认知障碍、淡漠和疲劳之间的相关性。
J Neurol. 2018 Aug;265(8):1764-1771. doi: 10.1007/s00415-018-8913-9. Epub 2018 May 26.
5
The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.快速眼动睡眠行为障碍与嗅觉减退对帕金森病认知和运动表型的联合影响。
J Neurol Sci. 2016 Sep 15;368:374-8. doi: 10.1016/j.jns.2016.07.057. Epub 2016 Jul 26.
6
Low Serum Vitamin D Levels May Contribute to Gastric Dysmotility in de novo Parkinson's Disease.血清维生素D水平低可能导致新发帕金森病患者出现胃动力障碍。
Neurodegener Dis. 2016;16(3-4):199-205. doi: 10.1159/000441917. Epub 2016 Jan 7.
7
Identifying the potential role of serum miR-20a as a biomarker for olfactory dysfunction in patients with Parkinson's disease.鉴定血清 miR-20a 作为帕金森病患者嗅觉功能障碍的生物标志物的潜在作用。
Eur Arch Otorhinolaryngol. 2023 Oct;280(10):4509-4517. doi: 10.1007/s00405-023-08034-5. Epub 2023 Jun 1.
8
Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.评估帕金森病患者嗅觉障碍的新量表的验证。
Parkinsonism Relat Disord. 2012 May;18(4):358-61. doi: 10.1016/j.parkreldis.2011.12.001. Epub 2012 Jan 5.
9
Differences in odor identification among clinical subtypes of Parkinson's disease.帕金森病临床亚型间嗅觉识别的差异。
Eur J Neurol. 2011 Mar;18(3):425-9. doi: 10.1111/j.1468-1331.2010.03167.x.
10
Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson's disease.嗅觉功能障碍与早期初发性帕金森病壳核多巴胺周转率相关。
J Neural Transm (Vienna). 2020 Jan;127(1):9-16. doi: 10.1007/s00702-019-02122-9. Epub 2019 Dec 20.

引用本文的文献

1
Identifying the potential role of serum miR-20a as a biomarker for olfactory dysfunction in patients with Parkinson's disease.鉴定血清 miR-20a 作为帕金森病患者嗅觉功能障碍的生物标志物的潜在作用。
Eur Arch Otorhinolaryngol. 2023 Oct;280(10):4509-4517. doi: 10.1007/s00405-023-08034-5. Epub 2023 Jun 1.
2
Could Vitamins Have a Positive Impact on the Treatment of Parkinson's Disease?维生素对帕金森病的治疗能产生积极影响吗?
Brain Sci. 2023 Feb 6;13(2):272. doi: 10.3390/brainsci13020272.
3
Vitamin D in Neurological Diseases.维生素 D 与神经疾病
Int J Mol Sci. 2022 Dec 21;24(1):87. doi: 10.3390/ijms24010087.
4
Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson's Disease and Dopaminergic Treatment Adverse Events.维生素D受体的基因变异性影响帕金森病易感性及多巴胺能治疗的不良事件。
Front Aging Neurosci. 2022 Apr 19;14:853277. doi: 10.3389/fnagi.2022.853277. eCollection 2022.
5
Vitamin D and Parkinson's Disease.维生素D与帕金森病
Nutrients. 2022 Mar 14;14(6):1220. doi: 10.3390/nu14061220.
6
Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link.有证据表明维生素 D 可能在 COVID-19 中发挥作用:缺失的环节。
Indian J Pharmacol. 2021 Sep-Oct;53(5):394-402. doi: 10.4103/ijp.IJP_654_20.
7
Smell Regions in Patients with Vitamin D Deficiency: An MRI Evaluation.维生素D缺乏患者的嗅觉区域:一项MRI评估
J Neurol Surg B Skull Base. 2021 Oct;82(5):593-600. doi: 10.1055/s-0040-1722227. Epub 2021 Jan 19.
8
Association of 25-hydroxyvitamin D status with brain volume changes.25-羟基维生素D状态与脑容量变化的关联。
Food Sci Nutr. 2021 Jun 15;9(8):4169-4175. doi: 10.1002/fsn3.2382. eCollection 2021 Aug.
9
Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases.饮食和保护因素可阻止或减轻自身免疫、COVID-19 及其相关代谢性疾病的进展。
Int J Mol Sci. 2021 Mar 19;22(6):3134. doi: 10.3390/ijms22063134.
10
The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson's disease.维生素 D、维生素 D 受体基因多态性与维生素 D 补充与帕金森病的关系。
Transl Neurodegener. 2020 Sep 1;9(1):34. doi: 10.1186/s40035-020-00213-2.